The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Epidemiology of the non-Hodgkin’s lymphomas: Distributions of the major subtypes differ by geographic locations
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer Incidence in Five Continents
(1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,501
Harris, N., Jaffe, E., Stein, H., Banks, P., Chan, J., Cleary, M., Delsol, G., De Wolf- Peeters, C., Falini, B., & Gatter, K. (1994) · Blood · doi:10.1182/blood.v84.5.1361.1361 · Cited by 6,327
Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
Celermajer, D. S., Sorensen, K. E., Gooch, V. M., Spiegelhalter, D. J., Miller, O. I., Sullivan, I. D., Lloyd, J. K., & Deanfield, J. E. (1992) · The Lancet · doi:10.1016/0140-6736(92)93147-f · Cited by 4,742 · cited 2×
“Большинство клинических исследований посвящено оценке вазодилатирующей функции эндотелия, при этом наиболее часто применялись пробы с изучением эндотелийзависимой вазодилатации плечевой артерии [5, 7, 9].”
The Non-Hodgkin's Lymphoma Pathologic Classification Project (1982) · Cancer · doi:10.1002/1097-0142(19820515)49:10<2112::aid-cncr2820491024>3.0.co;2-2 · Cited by 3,059
The Non-Hodgkin's Lymphoma Classification Project (1997) · Blood · doi:10.1182/blood.v89.11.3909 · Cited by 2,461
Non-Hodgkin’s Lymphomas in Asia
Shih, L., & Liang, D. (1991) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30396-4 · Cited by 105
Herrinton, L. J., Goldoft, M., Schwartz, S. M., & Weiss, N. S. (1996) · Cancer Causes & Control · doi:10.1007/bf00051298 · Cited by 67
Immunohistological subtypes of non-hodgkin's lymphoma in Hong Kong Chinese
Ho, F. C. S., Loke, S. L., Hui, P., & Todd, D. (1986) · Pathology · doi:10.3109/00313028609087563 · Cited by 38
Role of nitric oxide in progression and regression of atherosclerosis.
Cooke, J. P. (1996) · PubMed · Cited by 36
Non-Hodgkin's lymphoma--clinicopathological pattern.
Ahmad, M., Khan, A. H., Mansoor, A., et al. (1992) · PubMed · Cited by 13
Cited by
International T-Cell Lymphoma Project (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.4558 · Cited by 2,108
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
Morin, R. D., Mendez-Lago, M., Mungall, A. J., Goya, R., Mungall, K. L., Corbett, R. D., Johnson, N. A., Severson, T. M., Chiu, R., Field, M., et al. (2011) · Nature · doi:10.1038/nature10351 · Cited by 1,614
Armitage, J. O., Gascoyne, R. D., Lunning, M. A., & Cavalli, F. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32407-2 · Cited by 1,176
Self-citationHorwitz, S., O'Connor, O. A., Pro, B., Illidge, T., Fanale, M., Advani, R., Bartlett, N. L., Christensen, J. H., Morschhauser, F., Domingo-Domenech, E., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32984-2 · Cited by 739
Coiffier, B., Pro, B., Prince, H. M., Foss, F., Sokol, L., Greenwood, M., Caballero, D., Borchmann, P., Morschhauser, F., Wilhelm, M., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.4223 · Cited by 680
Shankland, K. R., Armitage, J. O., & Hancock, B. W. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60605-9 · Cited by 641
Self-citationPastore, A., Jurinovic, V., Kridel, R., Hoster, E., Staiger, A. M., Szczepanowski, M., Pott, C., Kopp, N., Murakami, M., Horn, H., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00169-2 · Cited by 618
Epidemiology of non-Hodgkin?s lymphoma (NHL): trends, geographic distribution, and etiology
M�ller, A. M. S., Ihorst, G., Mertelsmann, R., & Engelhardt, M. (2005) · Annals of Hematology · doi:10.1007/s00277-004-0939-7 · Cited by 493
Weisenburger, D. D., Savage, K. J., Harris, N. L., Gascoyne, R. D., Jaffe, E. S., MacLennan, K. A., Rüdiger, T., Pileri, S., Nakamura, S., Nathwani, B., et al. (2011) · Blood · doi:10.1182/blood-2010-09-310342 · Cited by 431
Self-citationRüdiger, T., Weisenburger, D. D., Anderson, J. R., Armitage, J. O., Diebold, J., MacLennan, K. A., Nathwani, B. N., Ullrich, F., & Müller-Hermelink, H. K. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf033 · Cited by 419
Self-citationNon-Hodgkin Lymphoma: Diagnosis and Treatment
Ansell, S. M., & Armitage, J. (2005) · Mayo Clinic Proceedings · doi:10.4065/80.8.1087 · Cited by 356
Self-citationThe non-Hodgkin lymphomas: A review of the epidemiologic literature
Alexander, D. D., Mink, P. J., Adami, H.-O., Chang, E. T., Cole, P., Mandel, J. S., & Trichopoulos, D. (2007) · International Journal of Cancer · doi:10.1002/ijc.22719 · Cited by 343
Fu, K., Weisenburger, D. D., Choi, W. W. L., Perry, K. D., Smith, L. M., Shi, X., Hans, C. P., Greiner, T. C., Bierman, P. J., Bociek, R. G., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.9277 · Cited by 334
Self-citationOncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma
Song, T. L., Nairismägi, M.-L., Laurensia, Y., Lim, J.-Q., Tan, J., Li, Z.-M., Pang, W.-L., Kizhakeyil, A., Wijaya, G.-C., Huang, D.-C., et al. (2018) · Blood · doi:10.1182/blood-2018-01-829424 · Cited by 326
Differences in incidence and trends of haematological malignancies in Japan and the United States
Chihara, D., Ito, H., Matsuda, T., Shibata, A., Katsumi, A., Nakamura, S., Tomotaka, S., Morton, L. M., Weisenburger, D. D., & Matsuo, K. (2014) · British Journal of Haematology · doi:10.1111/bjh.12659 · Cited by 310
Self-citationPathogenesis of follicular lymphoma
Kridel, R., Sehn, L. H., & Gascoyne, R. D. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63186 · Cited by 310
Follicular Lymphoma in the United States: First Report of the National LymphoCare Study
Friedberg, J. W., Taylor, M. D., Cerhan, J. R., Flowers, C. R., Dillon, H., Farber, C. M., Rogers, E. S., Hainsworth, J. D., Wong, E. K., Vose, J. M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.1495 · Cited by 294
Salaverria, I., Philipp, C., Oschlies, I., Kohler, C. W., Kreuz, M., Szczepanowski, M., Burkhardt, B., Trautmann, H., Gesk, S., Andrusiewicz, M., et al. (2011) · Blood · doi:10.1182/blood-2011-01-330795 · Cited by 292
Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma
Streubel, B., Vinatzer, U., Willheim, M., Raderer, M., & Chott, A. (2006) · Leukemia · doi:10.1038/sj.leu.2404045 · Cited by 279
Sun, J., Yang, Q., Lu, Z., He, M., Gao, L., Zhu, M., Sun, L., Wei, L., Li, M., Liu, C., et al. (2012) · American Journal of Clinical Pathology · doi:10.1309/ajcp7yltqpusdq5c · Cited by 271
Wu, S.-J., Chiang, C.-J., Lin, C.-T., Tien, H.-F., & Lai, M.-S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062930 · Cited by 19
“Chronic lymphocytic leukemia (CLL) is the most common leukemia in adults in Western countries, accounting for 5–11% of non-Hodgkin lymphomas [1,2,3].”
Background
Metadata
- Authors
- Anderson, J. R., Armitage, J. O., & Weisenburger, D. D.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 1998-07
- Volume
- 9
- Issue
- 7
- Pages
- 717-720
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2138498369
- Cited by
- 674
- References
- 10
- FWCI
- 5.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.